1. Home
  2. COOK vs PLX Comparison

COOK vs PLX Comparison

Compare COOK & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

HOLD

Current Price

$0.91

Market Cap

184.8M

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$1.74

Market Cap

204.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
PLX
Founded
1985
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.8M
204.9M
IPO Year
2021
1998

Fundamental Metrics

Financial Performance
Metric
COOK
PLX
Price
$0.91
$1.74
Analyst Decision
Hold
Strong Buy
Analyst Count
7
1
Target Price
$2.04
$12.00
AVG Volume (30 Days)
675.8K
560.5K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$582,799,000.00
$61,840,000.00
Revenue This Year
N/A
$14.29
Revenue Next Year
N/A
$16.65
P/E Ratio
N/A
$25.34
Revenue Growth
N/A
35.41
52 Week Low
$0.71
$1.32
52 Week High
$3.31
$3.10

Technical Indicators

Market Signals
Indicator
COOK
PLX
Relative Strength Index (RSI) 53.62 38.71
Support Level $0.71 $1.68
Resistance Level $0.84 $1.78
Average True Range (ATR) 0.09 0.09
MACD 0.01 0.01
Stochastic Oscillator 60.08 43.48

Price Performance

Historical Comparison
COOK
PLX

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: